Maria Martinez Selected Research

Therapeutics

3/2021	PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.
12/2020	Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumab.
1/2020	Development of a patient-reported outcome questionnaire for aplastic anemia and paroxysmal nocturnal hemoglobinuria (PRO-AA/PNH).
1/2016	Ten-Year Experience of Vascular Surgeon Management of Iatrogenic Pseudoaneurysms: Do Anticoagulant and/or Antiplatelet Medications Matter?
2/2011	Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria Martinez Research Topics

Disease

6	Parkinson Disease (Parkinson's Disease) 12/2019 - 07/2005
3	Neoplasms (Cancer) 03/2021 - 01/2017
3	Schizophrenia (Dementia Praecox) 01/2007 - 10/2004
2	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2013
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Hemophilia A (Haemophilia) 01/2022 - 12/2020
2	Hemorrhage 12/2020 - 10/2015
1	Restless Legs Syndrome (Restless Legs) 01/2022
1	Infections 10/2021
1	Neutropenia 10/2021
1	Hepatocellular Carcinoma (Hepatoma) 03/2021
1	Fatigue 01/2021
1	Metrorrhagia (Spotting) 12/2020
1	Thrombotic Microangiopathies 04/2020
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2020
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 01/2020
1	Nephritis 01/2020
1	IgA Vasculitis (Purpura, Schoenlein Henoch) 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 11/2019
1	Autoimmune Diseases (Autoimmune Disease) 06/2017
1	Osteosarcoma (Osteogenic Sarcoma) 01/2017
1	Marfan Syndrome (Marfan's Syndrome) 12/2016
1	False Aneurysm (Pseudoaneurysm) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2015
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 04/2015
1	Bipolar Disorder (Manic Depressive Psychosis) 04/2015
1	Systemic Scleroderma (Systemic Sclerosis) 06/2012
1	Fibrosis (Cirrhosis) 06/2012
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2009
1	Hepatitis 01/2009
1	Sclerosteosis 10/2008
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 10/2008
1	Iron Deficiencies 01/2007
1	Iron Overload 01/2007
1	Hemochromatosis (Bronze Diabetes) 01/2007
1	Communicable Diseases (Infectious Diseases) 07/2006
1	Atrophy 09/2004
1	Myotonic Dystrophy (Dystrophia Myotonica) 09/2004
1	Myotonic Disorders (Paramyotonia Congenita) 09/2004

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 10/2021 - 07/2006
3	Biological ProductsIBA 12/2019 - 10/2013
2	Phosphotransferases (Kinase)IBA 01/2022 - 03/2007
2	NivolumabIBA 01/2022 - 03/2021
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 10/2015
2	AnticoagulantsIBA 01/2016 - 10/2015
2	Crack CocaineIBA 01/2009 - 07/2006
1	regorafenibIBA 01/2022
1	3-hydroxyflavoneIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Protein Tyrosine PhosphatasesIBA 01/2022
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 10/2021
1	Valganciclovir FDA Link 10/2021
1	SteroidsIBA 10/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2021
1	IpilimumabIBA 03/2021
1	pembrolizumabIBA 01/2021
1	ibrutinibIBA 01/2021
1	Alkaline PhosphataseIBA 01/2021
1	Factor VIII (Coagulation Factor VIII)IBA 12/2020
1	emicizumabIBA 12/2020
1	Complement System Proteins (Complement)IBA 01/2020
1	LectinsIBA 01/2020
1	SolutionsIBA 01/2017
1	Transforming Growth Factor-beta Type I ReceptorIBA 12/2016
1	Hemostatics (Antihemorrhagics)IBA 10/2015
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2015
1	Vitamin K FDA Link 10/2015
1	Tranexamic Acid (AMCA)FDA Link 10/2015
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 10/2015
1	Fibrin Tissue Adhesive (Fibrin Sealant)IBA 10/2015
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 10/2015
1	Caveolin 1IBA 06/2012
1	Low Density Lipoprotein Receptor-Related Protein-5IBA 10/2008
1	Collagen Type I (Type I Collagen)IBA 10/2008
1	RANK LigandIBA 10/2008
1	Leucine (L-Leucine)FDA Link 03/2007
1	IronIBA 01/2007
1	AntioxidantsIBA 01/2007
1	DysbindinIBA 01/2007
1	ferric citrate iron reductase (ferric-chelate reductase)IBA 01/2007
1	Neuregulin-1 (Neuregulin 1)IBA 11/2005
1	DNA (Deoxyribonucleic Acid)IBA 11/2005
1	ApolipoproteinsIBA 07/2005
1	Apolipoprotein E4IBA 07/2005
1	AminesIBA 10/2004
1	tau Proteins (tau Protein)IBA 09/2004
1	Protein Isoforms (Isoforms)IBA 09/2004
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 09/2004
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2002
1	Type II Tumor Necrosis Factor ReceptorsIBA 08/2002

Therapy/Procedure

5	Therapeutics 03/2021 - 02/2011
2	Immunotherapy 01/2022 - 01/2021
1	Kidney Transplantation 10/2021
1	Hematopoietic Stem Cell Transplantation 04/2020
1	Sutures (Suture) 10/2015
1	Oral Surgery (Maxillofacial Surgery) 10/2015
1	Ambulatory Care (Outpatient Care) 04/2015